Should You Buy Oklo Stock While It's Under $171?

Oklo (OKLO), an SMR company backed by Sam Altman, experienced a significant stock surge in 2024/2025 driven by AI's power demands and SMR potential, peaking near $171 before a recent pullback to ~$120. Despite nonbinding orders from data center operators, commercial operation for its reactors is not expected until 2030, presenting execution risk and requiring a long-term investment horizon even as the current price dip makes it an intriguing prospect.

Analysis

Oklo (OKLO) went public in 2024 via a SPAC co-founded by Sam Altman, positioning itself as a key player in small modular nuclear reactors (SMRs) to address the rapidly growing power demands of artificial intelligence. The stock experienced a significant surge in 2024 and 2025, reaching all-time highs near $171, driven by hype around AI and SMR technologies. However, shares have recently pulled back to approximately $120 as of November 5th, presenting a potential entry point.

Oklo specializes in SMR technology, a sector seeing broader interest with other players like NuScale Power and Cameco also experiencing stock surges. While NuScale has certified reactors in production, Oklo currently holds nonbinding order agreements from data center operators such as Equinix. Despite the significant market potential, Oklo's market capitalization remains under $20 billion, reflecting the nascent stage of the SMR industry.

The commercialization timeline for Oklo's SMR technology is extended, with a completed facility not expected online until 2030, introducing substantial execution risk. Furthermore, the SMR market is characterized by varying technological approaches, creating uncertainty regarding which solution will ultimately dominate. The current "mildly positive" sentiment and "speculative" tone surrounding Oklo underscore the long-term, high-risk, high-reward nature of this investment.

Key Decisions for Investors

• Investors should approach Oklo (OKLO) with a long-term investment horizon, recognizing the speculative nature and significant execution risks associated with its SMR technology's commercialization timeline extending to 2030.
• Closely monitor the conversion of Oklo's nonbinding order agreements into firm contracts and track regulatory progress and construction milestones for its facilities.
• Diversify exposure within the clean energy and SMR sectors, as technological leadership and market dominance are still uncertain among various SMR approaches and competitors like NuScale.